Prostaglandin EP1Receptor Subtype Selectivity Takes Shape
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Molecular Pharmacology
- Vol. 59 (6) , 1357-1359
- https://doi.org/10.1124/mol.59.6.1357
Abstract
The studies of [Ungrin et al. (2001)][1] describe the ligand binding and activation of the human prostaglandin (PG) receptor assayed with an extensive panel of ligands. PGs are a diverse family of autocoids whose synthesis is initiated by cyclooxygenase-mediated metabolism of the unsaturated 20-This publication has 15 references indexed in Scilit:
- Prostanoid Receptors: Structures, Properties, and FunctionsPhysiological Reviews, 1999
- Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypesPublished by Elsevier ,1998
- Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cellsBritish Journal of Pharmacology, 1997
- EP1 receptor antagonist blocks the diarrheagenic, but not cytoprotective, actions of a synthetic prostaglandinDrug Development Research, 1995
- 8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid,2-[3-[2-(furanylmethyl)thio]-1-oxopropyl]hydrazide (SC-51322): A potent PGE2 antagonist and analgesicBioorganic & Medicinal Chemistry Letters, 1994
- N-Substituted dibenzoxazepines as analgesic PGE2 antagonistsJournal of Medicinal Chemistry, 1993
- Prostanoid biosynthesis and mechanisms of actionAmerican Journal of Physiology-Renal Physiology, 1992
- ARACHIDONIC ACID METABOLISMAnnual Review of Biochemistry, 1986
- Studies of the characterisation of prostanoid receptors: A proposed classificationProstaglandins, 1982
- The sequence of the early steps in the metabolism of prostaglandin E1European Journal of Pharmacology, 1971